Results 231 to 240 of about 4,861,792 (337)

Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy

ESC Heart Failure, Volume 12, Issue 2, Page 1029-1044, April 2025.
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo, Tor Biering‐Sorensen, Joao P. Ferreira, Carlo Mario Lombardi, Andrea Bonelli, Andrea Garascia, Marco Metra, Riccardo M. Inciardi   +7 more
wiley   +1 more source

ML enhanced bioactivity prediction for angiotensin II receptor: A potential anti-hypertensive drug target. [PDF]

Sci Rep
Sankar J, Rajendran V, Kuriakose BB, Alhazmi AH, Wong LS, Muthusamy K.   +5 more
europepmc   +1 more source

Angiotensin II receptors in adrenal cortex and uterus. Binding and activation properties of angiotensin analogues.

, 1979
A M Capponi, Kevin Catt
openalex   +1 more source

Electrophysiological study of the action of angiotensin II on the rat myometrium. [PDF]

, 1979
G Hamon, Manuel Worcel
openalex   +1 more source

Left ventricular function improvement during angiotensin receptor–neprilysin inhibitor treatment in a cohort of HFrEF/HFmrEF patients

ESC Heart Failure, Volume 12, Issue 2, Page 1151-1165, April 2025.
Prediction of LVEF improvement in patients with HFrEF and HFmrEF following treatment with Sacubitril/Valsartan. Workflow of this study investigating the functional capacity improvement in response to Sacubitrail/Valsartsan in a real‐world scenario of heart failure treatment.
Florian Appenzeller, Tobias Harm, Manuel Sigle, Parwez Aidery, Klaus‐Peter Kreisselmeier, Livia Baas, Andreas Goldschmied, Meinrad Paul Gawaz, Karin Anne Lydia Müller   +8 more
wiley   +1 more source

The angiotensin II type 2 receptor attenuates aging-associated arterial stiffness in female mice. [PDF]

Am J Physiol Heart Circ Physiol
Turner CG, Kenney R, Vorn J, Kim SK, Martin G, Pulakat L, Jaffe IZ, DuPont JJ.   +7 more
europepmc   +1 more source

Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice.

Journal of Clinical Investigation, 2000
A. Daugherty, Michael W. Manning, L. Cassis   +2 more
semanticscholar   +1 more source

The effects of sodium–glucose cotransporter 2 inhibitors on the ‘forgotten’ right ventricle

ESC Heart Failure, Volume 12, Issue 2, Page 1045-1058, April 2025.
Abstract With the progress in diagnosis, treatment and imaging techniques, there is a growing recognition that impaired right ventricular (RV) function profoundly affects the prognosis of patients with heart failure (HF), irrespective of their left ventricular ejection fraction (LVEF).
Liangzhen Qu, Xueting Duan, Han Chen
wiley   +1 more source

Angiotensin II, conventional vasopressor therapy, and mortality in shock: a large, multicenter, propensity score-weighted analysis. [PDF]

Ann Intensive Care
Busse LW, Ten Lohuis C, Xu H, Jannuzzo C, Lyles RH, Teixeira JP, Mehta I, Liu Y.   +7 more
europepmc   +1 more source

Angiotensin II, NADPH oxidase, and redox signaling in the vasculature.

Antioxidants and Redox Signaling, 2013
A. Nguyen Dinh Cat, A. Montezano, D. Burger, R. Touyz   +3 more
semanticscholar   +1 more source